RxDoctor Payments Data

Marcelo Rocha, MD

Vascular Neurology · Pittsburgh, PANPI 1861712333

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Viz.ai, Inc. accounts for 71.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for vascular neurology clinicians in PA, where the typical reported total is $349.

$53in general payments, 2019–2025

Across 3 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viz.ai, Inc.$38
  • Johnson & Johnson$15
$163,785in research payments, 2019–2025

Across 7 payments — averaging $23,398 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$164K
  • Alnylam Pharmaceuticals Inc.$216

What the payments were for

  • Food & beverage$53100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viz.ai, Inc.2$38
Johnson & Johnson1$15

How this compares

$53 in reported general payments places this provider in the 20th percentile of 52 vascular neurology providers in Pennsylvania.

See all vascular neurology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$19,620
Medicare patients
84
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular neurology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →